Enhanced External Counterpulsation as a Novel Treatment for Post-acute COVID-19 Sequelae

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for the coronavirus disease 2019 (COVID-19) pandemic. As patients recover from COVID-19, some continue to report persisting symptoms weeks to months after acute infection. These effects have been referred to as pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Dayrit, Joshua Kyle, Verduzco-Gutierrez, Monica, Teal, Ann, Shah, Sachin A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110286/
https://www.ncbi.nlm.nih.gov/pubmed/33987042
http://dx.doi.org/10.7759/cureus.14358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110286/
https://www.ncbi.nlm.nih.gov/pubmed/33987042
http://dx.doi.org/10.7759/cureus.14358

Ejemplares similares